z-logo
Premium
Assessment of tumour‐associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma
Author(s) -
Dagher Julien,
Delahunt Brett,
RiouxLeclercq Nathalie,
Egevad Lars,
Coughlin Geoff,
Dunglison Nigel,
Gianduzzo Troy,
Kua Boon,
Malone Greg,
Martin Ben,
Preston John,
Pokorny Morgan,
Wood Simon,
Samaratunga Hemamali
Publication year - 2019
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/his.13737
Subject(s) - medicine , grading (engineering) , renal cell carcinoma , nephrectomy , multivariate analysis , clear cell , clear cell renal cell carcinoma , carcinoma , cancer staging , metastasis , univariate analysis , pathological , pathology , cancer , oncology , kidney , civil engineering , engineering
Aims The aims of this study were to evaluate the impact of tumour‐associated necrosis ( TAN ) on metastasis‐free survival for clear cell renal cell carcinoma ( RCC ), and to determine whether TAN provides survival information additional to World Health Organization ( WHO )/International Society of Urological Pathology ( ISUP ) grading. Methods and results The study consisted of 376 cases of clear cell RCC treated by nephrectomy, for which follow‐up was available. WHO / ISUP grade was assigned, and sections were assessed for the presence of TAN . American Joint Committee on Cancer ( AJCC ) pT staging category and tumour size were also recorded. The development of metastatic disease was taken as the clinical endpoint, and survival analyses, utilising univariate and multivariate models, were performed. WHO / ISUP grades were: grade 1, 35 cases (9.3%); grade 2, 188 cases (50.0%); grade 3, 91 cases (24.2%); and grade 4, 62 cases (16.5%). Staging categories were pT 1– pT 2 [234 tumours (62.2%)] and pT 3– pT 4 [139 tumours (37.0%)]. TAN was seen in 128 cases (34.0%). Neither TAN nor metastases were seen in grade 1 tumours. Among grade 2–4 tumours, those with TAN had a significantly worse prognosis than those without TAN ( P  = 0.017, P  = 0.04, and P  = 0.006, respectively). Multivariate analysis ( WHO / ISUP grade, pT staging category, and TAN ) showed all three variables to be independently associated with outcome ( P  = 0.009, P  = 0.005, and P  = 0.001, respectively). For all tumour grades and pT staging categories, it was found that the presence of TAN was associated with a 2.91‐fold greater risk of metastatic disease. Conclusion Tumour‐associated necrosis is an important prognostic factor for clear cell RCC , independently of WHO / ISUP grade. This supports the suggestion that TAN could be incorporated into tumour grading criteria.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here